About Us

At OTAWA Health we are reshaping the landscape of oncology care through our Advanced Digital Oncology platform.

Our specialized Oncology Electronic Health Record and Clinical Decision Support system designed BY cancer care professionals FOR cancer care professionals, reshapes how cancer centers manage treatments while providing a comprehensive and coordinated patient care.

Our mission is focused in:

  • Delivering top-tier cancer care solutions
  • Collecting oncology structured Real-World Data for Real-World Evidence studies
  • Enhancing patient outcomes
  • Contributing to the development of more effective cancer treatments.

Born from the IT team of one of Brazil’s most respected oncology centers (www.cccancer.net), OTAWA Health proudly carries forward alegacy of excellence and innovation in oncology care.

Join us in our commitment to transform the future of cancer care. Your journey to better oncology management starts here.

Spin Out Company
Global Health Transformer Company
Connected Company
Winner "AI for COVID-19"
National Challenge

Miletsones

our history

Our journey began when the IT team at Centro de Combate ao Câncer (CCC) initiated the development of a specialized oncology EHR/CDS system for internal use.

Centro de Combate ao Câncer

2010

The genesis of OTAWA Health took shape as we embarked on a project to emerge as an independent company from CCC.

Even before our official incorporation, Startup Health recognized us as a disruptor in the ‘End Cancer’ and ‘Cost to Zero’ moonshots, welcoming us into their Global Army of Health Transformers.

Startutp Health - Partner Otawa HEalth

2019

This year witnessed multiple successes.

We secured our second seed funding round and extended the use of OTWonco to two additional oncology centers.

We began the migration to a FHIR HL7 and HIPAA compliant cloud-based solution.

One achievement stood out as a testament to our commitment to social responsibility. In response to the COVID-19 pandemic, we voluntarily devoted our resources to a pro-bono effort – creating an AI platform to detect COVID-19 in chest x-ray images.

This platform was built to assist overwhelmed physicians in emergency rooms across the country. Our efforts were rewarded when AIIA won the “Artificial Intelligence against COVID-19” national challenge hosted by IdeiaGov, the innovation hub of the Government of the State of São Paulo, and by InRad, the radiology department of Hospital das Clínicas.

Ideagov - São Paulo

2021

Our growth continued as we extended our services to five oncology centers.

OTAWA Health also entered into a partnership to introduce OTWonco to Rwanda and other Eastern African Community countries, bringing our innovative solutions to a combined population of 200 million in Africa.

2023

2007

The in-house developed system at CCC took full control of cancer care management, marking a major milestone in our healthcare innovation journey.

2016

The year marked our official spin-off from CCC in late December.

Our in-house developed oncology EHR/CDS earned the names OTWonco and OTWdecision.

We also raised our first external seed funding round.

2020

We expanded our reach to four oncology centers and were selected as a UCSF Health Hub Connected Company.

We also made our mark by being chosen for the 3rd USCF Health Awards “Breakthrough COVID-19 Technology”.

2022

Signed a partnership with IQVIA Brasil which selected OTAWA Health as a data provider for oncology studies, recognizing the robustness of our Real-World Oncology Data

2007
  • 2007

Our journey began when the IT team at Centro de Combate ao Câncer (CCC) initiated the development of a specialized oncology EHR/CDS system for internal use.

  • 2010

The in-house developed system at CCC took full control of cancer care management, marking a major milestone in our healthcare innovation journey.

2016
  • 2016

The genesis of OTAWA Health took shape as we embarked on a project to emerge as an independent company from CCC.

Even before our official incorporation, Startup Health recognized us as a disruptor in the ‘End Cancer’ and ‘Cost to Zero’ moonshots, welcoming us into their Global Army of Health Transformers.

2019
  • 2019

The year marked our official spin-off from CCC in late December.

Our in-house developed oncology EHR/CDS earned the names OTWonco and OTWdecision.

We also raised our first external seed funding round.

2010
  • 2020

This year witnessed multiple successes.

We secured our second seed funding round and extended the use of OTWonco to two additional oncology centers.

We began the migration to a FHIR HL7 and HIPAA compliant cloud-based solution.

One achievement stood out as a testament to our commitment to social responsibility. In response to the COVID-19 pandemic, we voluntarily devoted our resources to a pro-bono effort – creating an AI platform to detect COVID-19 in chest x-ray images.

This platform was built to assist overwhelmed physicians in emergency rooms across the country. Our efforts were rewarded when AIIA won the “Artificial Intelligence against COVID-19” national challenge hosted by IdeiaGov, the innovation hub of the Government of the State of São Paulo, and by InRad, the radiology department of Hospital das Clínicas.

2021
  • 2021

We expanded our reach to four oncology centers and were selected as a UCSF Health Hub Connected Company.

We also made our mark by being chosen for the 3rd USCF Health Awards “Breakthrough COVID-19 Technology”.

2022
  • 2022

Our growth continued as we extended our services to five oncology centers.

OTAWA Health also entered into a partnership to introduce OTWonco to Rwanda and other Eastern African Community countries, bringing our innovative solutions to a combined population of 200 million in Africa.

Our Journey Continues

As we reflect on our milestones, we are immensely proud of what we've achieved at OTAWA Health. However, we believe that our journey is just beginning. Paulo Gusmão - Cofounder, CEO

Our commitment goes beyond developing innovative technology. We strive to bring value to all stakeholders in the field of oncology, as well as to patients. Through the use of personalized diagnostic parameters and predefined treatment protocols using evidence-based medicine, we facilitate standardization of processes and procedures.

For patients, we aim to improve the overall quality and safety of treatment, contributing to better outcomes. For cancer centers, we provide tools for better management, treatment standardization, curated clinical decision support, and cost transparency, thereby reducing unjustified variability. For HMOs, our approach offers treatment cost transparency, predictability, and better managed cancer centers. For Pharma, we provide structured oncology Real-Word Data sets to support Real-World Evidence studies.

With every step we take, we remain committed to our mission: transforming cancer care and making a significant difference in the lives of patients and healthcare professionals. We envision a future where every cancer center can provide comprehensive, coordinated care underpinned by cutting-edge technology, and we’re working diligently to make this vision a reality.

We invite you to join us on this journey. Together, we can continue to shape the future of oncology.